In a scathing decision by the United States District Court for the Southern District of New York, the Court denied class certification of the Allergan securities class action (“Allergan”). See In re Allergan PLC Sec. Litig.,...more
10/21/2020
/ Class Action ,
Class Certification ,
Class Members ,
Class Representatives ,
FRCP 23 ,
FRCP 23(b)(3) ,
Institutional Investors ,
Legal Fees ,
Question of Fact ,
Question of Law ,
Securities Fraud ,
Securities Litigation
As we previously noted in this post, the United States District Court for the Northern District of California dismissed the Volkswagen Bondholder Plaintiff’s first amended complaint, with leave to amend, holding that it could...more